Recent trends in breast cancer incidence and mortality in Europe and North America;Aktuelle entwicklung der inzidenz und mortalität beim mammakarzinom

Gynakologe

Volumn 36, Issue 9, 2003, Pages 746-752

  Hubbel V F ^a   Rhiem, K ^a   Warm, M ^a   Mallmann, P ^a   Schmutzler, R K ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Breast cancer; Incidence; Mammography screening; Mortality; Prevention

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; EUROPE; FEMALE; GERMANY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NORTH AMERICA; RELIABILITY; REVIEW;

EID: 0141818087     PISSN: 00175994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00129-003-1412-8     Document Type: Review

References (32)

1. Ferlay J (2001) Globocan 2000. International Agency for Research on Cancer. World Health Organisation, Genf
2. Robert-Koch-Institut (2003) Brustkrebsinzidenz und -mortalität in Deutschland. Robert-Koch-Institut, Berlin
3. Parkin DM (1997) Cancer Incidence in Five Continents, Vol. I-VII. IARC Scientific Publications, Lyon
4. Krebsregister (2003) Brustkrebsinzidenz und -mortalität. Krebsregister, Münster
5. Statistisches Bundesamt (2001) Todesursachenstatistik 2001. Statistisches Bundesamt, Berlin
6. IARC (2003) Incidence, mortality and prevalence database. international agency for research on cancer. World Health Organization, Genf (www.iacr.fr)
7. Sant M (1998) Survival of Women with Breast Cancer in Europe: Variation with age, year of diagnosis and country. Int J Cancer 77:679-683
8. Becker N, Wahrendorf J (1997) Atlas of cancer mortality in the Federal Republic of Germany 1981-1990. Springer, Berlin Heidelberg New York
9. Wald N (1994) Consensus conference on breast cancer screening: The effect of screening on breast cancer mortality. Oncology 51:380-389
10. Hendrick RE (1997) Benefit of screening mammography in women ages 40-49: A meta-analysis of new randomized controlled trial results. American Cancer Society Workshop on Guidelines for Breast Cancer Detection
11. Gibis B (1997) Das Mammographie-Screening als Verfahren zu Brustkrebsfrüherkennung. Nomos, Baden-Baden
12. Olsen O, Gotzsche PC (2001) Cochrane review on screening for breast cancer with mammography. Lancet 358: 1340-1342
13. L Nystrom (2002) Long-term effects of mammography screening: updated overview of the Swedisch randomised trials. Lancet 359: 909-919
14. Peeters PHM (1989) The occurance of interval cancers in the Nijmegen screening programme. Br J Cancer 59: 929-932
15. Shapiro S (1988) Determining the efficacy of breast cancer screening. Cancer 63: 1873-1880
16. Frischbier HJ, Hoeffken W, Robra BP (1994) Mammographie in der Krebsfrüherkennung, Qualitätssicherung und Akzeptanz. Enke, Stuttgart
17. Peer PGM (1993) Age-depent groth rate of primary breast cancer. Cancer 71: 3547-3551
18. Hennekens CH (1987) Epidemiology in medicine. Little, Brown & Co, Boston Toronto
19. Page DL (1982) Intaductal carcinoma of the breast: follow up after biopsy only. Cancer 49: 751-758
20. Lebeau A (2000) Nicht invasive Karzinome der Brust, Biologie und prognostische Relevanz. In: Untch M (Hrsg) Diagnostik und Therapie des Mammakarzinoms. Zuckerschwert, München Bern, S 135-146
21. Europäisches Parlament 1994
22. NCI. (1998) National-Cancer-Institute
23. Early (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 339: 1-85
24. Barnett JB (2003) The relationship between obesity and breast cancer risk and mortality. Nutr Rev 61: 73-76
25. Nelson HD (2002) Postmenopausal hormone replacement therapy: scientific review. JAMA 228: 872-881
26. Schmutzler RK, Beckmann MW, Kiechle M (1999) Familiäres Mamma- und Ovarialkarzinom. Dtsch Ärzteblatt 20:1372
27. Salih AK, Fentiman IS (2001) Breast cancer prevention: present and future. Cancer Treat Rev 27:261-273
28. Veronesi U (2003) Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women. J Natl Cancer Inst 95:91-93
29. Powles T (1998) Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet 11:98-101
30. Powles TJ (2002) Breast cancer prevention. Oncologist 7: 60-64
31. IBIS-Investigators (2002) First results from the International Breast Cancer Intervention Study (IBIS-I): a randomized prevention trial. Lancet 360: 817-324
32. Freedman AN (2003) Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention. J Natl Cancer Inst 95: S26-532